Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trialLancet neurology, 2020-02, Vol.19 (2), p.115-122 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(19)30395-3 ;PMID: 31831388Full text available |
|
2 |
Material Type: Article
|
Percutaneous Repair or Medical Treatment for Secondary Mitral RegurgitationThe New England journal of medicine, 2018-12, Vol.379 (24), p.2297-2306 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1805374 ;PMID: 30145927Full text available |
|
3 |
Material Type: Article
|
Gastric cancerThe Lancet (British edition), 2020-08, Vol.396 (10251), p.635-648 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31288-5Full text available |
|
4 |
Material Type: Article
|
Baricitinib as potential treatment for 2019-nCoV acute respiratory diseaseThe Lancet, 2020-02, Vol.395 (10223), p.e30-e31 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30304-4 ;PMID: 32032529Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Progress towards therapies for disease modification in Parkinson's diseaseLancet neurology, 2021-07, Vol.20 (7), p.559-572 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(21)00061-2Full text available |
|
6 |
Material Type: Article
|
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical TrialJAMA, 2020-08, Vol.324 (5), p.460 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.10044Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant EnterobacteriaceaeClinical infectious diseases, 2018-01, Vol.66 (2), p.163-171 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;Copyright Oxford University Press, UK Jan 15, 2018 ;The Author(s) 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2017 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/cix783 ;PMID: 29020404Full text available |
|
8 |
Material Type: Article
|
Determinants of ICS Therapy Adherence in Patients With AsthmaThe American journal of managed care, 2021-02, Vol.27 (2), p.1 [Peer Reviewed Journal]Copyright Intellisphere, LLC Feb 2021 ;ISSN: 1088-0224 ;EISSN: 1936-2692Full text available |
|
9 |
Material Type: Article
|
Anxiety disordersThe Lancet (British edition), 2021-03, Vol.397 (10277), p.914-927 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00359-7 ;PMID: 33581801Full text available |
|
10 |
Material Type: Article
|
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort studyThe Lancet, 2020-06, Vol.395 (10241), p.1919-1926 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31173-9 ;PMID: 32473682Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19New England Journal of Medicine, 2022-04, Vol.386 (15), p.1397-1408 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2118542 ;PMID: 35172054Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes care, 2018-12, Vol.41 (12), p.2669-2701 [Peer Reviewed Journal]2018 American Diabetes Association and European Association for the Study of Diabetes. ;Copyright American Diabetes Association Dec 1, 2018 ;2018 American Diabetes Association and European Association for the Study of Diabetes. 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci18-0033 ;PMID: 30291106Full text available |
|
13 |
Material Type: Article
|
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisLeukemia, 2019-01, Vol.33 (1), p.159-170 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-018-0196-8 ;PMID: 29967379Full text available |
|
14 |
Material Type: Article
|
Potential effects of curcumin in the treatment of COVID‐19 infectionPhytotherapy Research, 2020-11 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/ptr.6738Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patientsEuropean journal of cancer (1990), 2019-07, Vol.116, p.116-136 [Peer Reviewed Journal]Attribution - NonCommercial ;ISSN: 0959-8049 ;EISSN: 1879-0852 ;DOI: 10.1016/j.ejca.2019.04.031Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Pathophysiology, diagnosis, and management of endometriosisBMJ (Online), 2022-11, Vol.379, p.e070750 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2022BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2022-070750 ;PMID: 36375827Full text available |
|
17 |
Material Type: Article
|
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2019-10, Vol.394 (10208), p.1540-1550 [Peer Reviewed Journal]2019 Elsevier Ltd ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32135-XFull text available |
|
18 |
Material Type: Article
|
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020-04, Vol.323 (16), p.1574 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.5394Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in EnglandThe Lancet (British edition), 2020-08, Vol.396 (10248), p.381-389 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31356-8 ;PMID: 32679111Full text available |
|
20 |
Material Type: Article
|
AB0207 ANALYSIS OF ABATACEPT TREATMENT RETENTION AND EFFICACY ACCORDING TO DISEASE DURATION AND TREATMENT LINE IN A REAL-WORLD SETTINGAnnals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1128-1130 [Peer Reviewed Journal]2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-eular.955Full text available |